Denis Chem Lab Ltd vs Speciality Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Denis Chem Lab Ltd is ₹ 78.38 as of 30 Apr 15:30 . The P/E Ratio of Denis Chem Lab Ltd changed from 22.9 on March 2021 to 15.9 on March 2025 . This represents a CAGR of -7.04% over 5 yearsThe P/E Ratio of Speciality Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Denis Chem Lab Ltd changed from ₹ 51.83 crore on March 2021 to ₹ 128.57 crore on March 2025 . This represents a CAGR of 19.93% over 5 yearsThe Market Cap of Speciality Medicines Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Denis Chem Lab Ltd for the Dec '25 is ₹ 45.96 crore as compare to the Sep '25 revenue of ₹ 46.82 crore. This represent the decline of -1.84% The revenue of Speciality Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Denis Chem Lab Ltd for the Dec '25 is ₹ 6.46 crore as compare to the Sep '25 ebitda of ₹ 4.91 crore. This represent the growth of 31.57% The ebitda of Speciality Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Denis Chem Lab Ltd changed from ₹ 2.08 crore to ₹ 3.32 crore over 7 quarters. This represents a CAGR of 30.63% The net profit of Speciality Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Denis Chem Lab Ltd changed from 46.06 % on March 2021 to 25.77 % on March 2025 . This represents a CAGR of -10.97% over 5 yearsThe Dividend Payout of Speciality Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Denis Chem Lab Ltd

Denis Chem Lab Limited was incorporated in 1980 and was converted into a Public Limited Company in 1982.
The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology. The Company is engaged in manufacturing of Pharmaceuticals Transfusion Solution in Bottles.
The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms. These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml.

About Speciality Medicines Ltd

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

FAQs for the comparison of Denis Chem Lab Ltd and Speciality Medicines Ltd

Which company has a larger market capitalization, Denis Chem Lab Ltd or Speciality Medicines Ltd?

Market cap of Denis Chem Lab Ltd is 108 Cr while Market cap of Speciality Medicines Ltd is 290 Cr

What are the key factors driving the stock performance of Denis Chem Lab Ltd and Speciality Medicines Ltd?

The stock performance of Denis Chem Lab Ltd and Speciality Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Denis Chem Lab Ltd and Speciality Medicines Ltd?

As of May 4, 2026, the Denis Chem Lab Ltd stock price is INR ₹78.38. On the other hand, Speciality Medicines Ltd stock price is INR ₹330.45.

How do dividend payouts of Denis Chem Lab Ltd and Speciality Medicines Ltd compare?

To compare the dividend payouts of Denis Chem Lab Ltd and Speciality Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.